News
Top 5 Health Care Stocks That May Plunge In March
28 Mar 24
News, Penny Stocks, Short Ideas, Small Cap, Pre-Market Outlook, Markets, Trading Ideas
Recent Price Trend in ARS Pharmaceuticals, Inc. (SPRY) is Your Friend, Here's Why
26 Mar 24
News, Small Cap, Markets, Trading Ideas
CORRECTION: On Thursday March 21, 2024 ARS Pharmaceuticals Reported Q4 EPS $(0.07) Beats $(0.14) Estimate
22 Mar 24
Earnings, News
ARS Pharmaceuticals Q4 2023 GAAP EPS $(0.57) Misses $(0.14) Estimate
21 Mar 24
Earnings, Earnings Misses, News
Wedbush Reiterates Outperform on ARS Pharmaceuticals, Maintains $19 Price Target
11 Mar 24
News, Price Target, Reiteration, Analyst Ratings
ARS Pharmaceuticals Reviews Recent Clinical Updates And Commercial Opportunity At neffy Investor Day
7 Mar 24
Biotech, News, Events, General
Leerink Partners Upgrades ARS Pharmaceuticals to Outperform, Raises Price Target to $18
5 Mar 24
News, Upgrades, Price Target, Analyst Ratings
Allergic Reaction Focused ARS Pharmaceuticals' Lead Candidate Shows Efficacy In Skin Disorder
26 Feb 24
Biotech, Equities, News, Health Care, Movers, General
ARS Pharmaceuticals Announces neffy Meets Primary Endpoints And Shows Rapid Symptom Control In Phase 2 Urticaria Clinical Study
26 Feb 24
Biotech, News, General
ARS Pharma Readies Data In Response To FDA's Rejection For Its EpiPen Alternative For Severe Allergic Reactions
20 Feb 24
Analyst Color, Biotech, Equities, News, Upgrades, Health Care, FDA, Analyst Ratings, Trading Ideas, General
ARS Pharmaceuticals To Present Clinical Efficacy Data For neffy At 2024 AAAAI Annual Meeting
5 Feb 24
Biotech, News, Events, General
Press releases
ARS Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
21 Mar 24
Earnings, Press Releases
ARS Pharmaceuticals Reviews Recent Clinical Updates and Commercial Opportunity at neffy® Investor Day
7 Mar 24
News, Press Releases
ARS Pharmaceuticals to Participate in the Leerink Partners Global Biopharma Conference 2024
6 Mar 24
News, Press Releases
ARS Pharmaceuticals announces neffy® meets primary endpoints and shows rapid symptom control in Phase 2 urticaria clinical study
26 Feb 24
Press Releases
ARS Pharmaceuticals to Host Virtual neffy® Investor Day on March 7, 2024
22 Feb 24
Press Releases
ARS Pharmaceuticals to Present Positive Clinical Efficacy Data for neffy® (epinephrine nasal spray) at 2024 AAAAI Annual Meeting
5 Feb 24
News, Health Care, Press Releases, General